Who owns Bridgebio Pharma Inc?
- Ticker: BBIO
- CUSIP Number: 10806x102
Tip: Access positions for across all investors
Analyze quarterly positions in Bridgebio Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bridgebio Pharma stock
Who bought or sold Bridgebio Pharma Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 17M | $1.3B | 0% | Dec 2025 |
|
| BlackRock | 15M | $1.1B | 1% | Dec 2025 |
|
| Viking Global Investors | 14M | $1.1B | -10% | Dec 2025 |
|
| Kohlberg Kravis Roberts & Co | 13M | $689M | 0% | Sep 2025 |
|
| Farallon Capital Management | 9.0M | $688M | 10% | Dec 2025 |
|
| Henderson Group | 8.7M | $454M | 100% | Sep 2025 |
|
| UBS Group | 5.7M | $439M | -11% | Dec 2025 |
|
| Aisling Capital Management | 5.1M | $389M | -16% | Dec 2025 |
|
| State Street Corporation | 5.0M | $380M | -11% | Dec 2025 |
|
| Invesco | 4.8M | $370M | 23% | Dec 2025 |
|
| Geode Capital Management | 4.4M | $346M | 13% | Dec 2025 |
|
| Jane Street | 3.9M | $298M | -6% | Dec 2025 |
|
| Susquehanna International | 3.7M | $284M | -9% | Dec 2025 |
|
| Frazier Life Sciences Management | 3.5M | $271M | -8% | Dec 2025 |
|
| Two Sigma Investments | 2.3M | $121M | 0% | Sep 2025 |
|
| Alliancebernstein | 2.3M | $121M | -6% | Sep 2025 |
|
| D. E. Shaw & Co | 2.3M | $117M | 8% | Sep 2025 |
|
| Franklin Resources | 2.2M | $166M | 50% | Dec 2025 |
|
| Manufacturers Life Insurance Company | 2.0M | $151M | 3% | Dec 2025 |
|
| Charles Schwab Investment Management | 2.0M | $150M | 2% | Dec 2025 |
|
| Goldman Sachs Group | 1.9M | $148M | -16% | Dec 2025 |
|
| Capital Research Global Investors | 1.9M | $148M | 0% | Dec 2025 |
|
| Sc Us | 1.9M | $142M | 0% | Dec 2025 |
|
| FMR | 1.7M | $88M | -16% | Sep 2025 |
|
| Two Sigma Advisers | 1.7M | $86M | -1% | Sep 2025 |
|
| Driehaus Capital Management | 1.7M | $86M | -2% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.6M | $122M | 149% | Dec 2025 |
|
| Norges Bank Investment Management | 1.5M | $117M | 100% | Dec 2025 |
|
| Laurion Capital Management | 1.4M | $107M | -20% | Dec 2025 |
|
| Northern Trust | 1.3M | $103M | -4% | Dec 2025 |
|
| Principal Financial Group | 1.3M | $101M | 4% | Dec 2025 |
|
| Polar Capital Holdings | 1.3M | $99M | 32% | Dec 2025 |
|
| Pictet Asset Management Holding SA | 1.3M | $97M | 12% | Dec 2025 |
|
| Ensign Peak Advisors | 1.3M | $97M | -7% | Dec 2025 |
|
| Hood River Capital Management | 1.3M | $96M | 1% | Dec 2025 |
|
| Cormorant Asset Management | 1.2M | $92M | -14% | Dec 2025 |
|
| Balyasny Asset Management | 1.1M | $59M | -35% | Sep 2025 |
|
| American Century Companies | 1.1M | $85M | 3% | Dec 2025 |
|
| Wellington Management Company | 1.0M | $53M | 1699% | Sep 2025 |
|
| Allspring Global Investments Holdings | 994k | $78M | 14212% | Dec 2025 |
|
| Adage Capital Partners GP | 945k | $49M | 214% | Sep 2025 |
|
| Ameriprise Financial | 842k | $64M | 5% | Dec 2025 |
|
| Frontier Capital Management | 826k | $63M | 25% | Dec 2025 |
|
| Summit Partners Public Asset Management | 814k | $62M | 1% | Dec 2025 |
|
| Deep Track Capital | 810k | $62M | -32% | Dec 2025 |
|
| Lord, Abbett & Co | 781k | $60M | -11% | Dec 2025 |
|
| PanAgora Asset Management | 739k | $57M | 1% | Dec 2025 |
|
| Sofinnova Ventures | 720k | $55M | -13% | Dec 2025 |
|
| Paradigm Biocapital Advisors | 684k | $52M | 0% | Dec 2025 |
|
| Barclays | 643k | $49M | -13% | Dec 2025 |
|
| Voloridge Investment Management | 639k | $49M | 377% | Dec 2025 |
|
| Jennifer Ranahan | 626k | $48M | 5% | Dec 2025 |
|
| Bank of New York Mellon | 596k | $46M | -36% | Dec 2025 |
|
| First Turn Management | 596k | $46M | 1% | Dec 2025 |
|
| Federated Investors | 587k | $45M | 38% | Dec 2025 |
|
| Ing Investment Management | 583k | $45M | 23% | Dec 2025 |
|
| PRIMECAP Management Company | 570k | $44M | -1% | Dec 2025 |
|
| Nomura Holdings | 536k | $41M | -5% | Dec 2025 |
|
| Emerald Advisers | 536k | $41M | -26% | Dec 2025 |
|
| ClearBridge Advisors | 498k | $38M | 1% | Dec 2025 |
|
| Nuveen | 495k | $38M | -2% | Dec 2025 |
|
| Gilder, Gagnon, Howe & Co | 462k | $24M | -1% | Sep 2025 |
|
| Ubs Global Asset Management Americas | 451k | $35M | -12% | Dec 2025 |
|
| Caption Management | 425k | $33M | 70% | Dec 2025 |
|
| Russell Investments | 415k | $32M | 8% | Dec 2025 |
|
| Diadema Partners | 410k | $31M | 212% | Dec 2025 |
|
| Citadel Advisors | 405k | $21M | -41% | Sep 2025 |
|
| Dimensional Fund Advisors | 383k | $29M | 461% | Dec 2025 |
|
| Deutsche Bank Aktiengesellschaft | 381k | $29M | -11% | Dec 2025 |
|
| Eventide Asset Management | 362k | $28M | -38% | Dec 2025 |
|
| Royal Bank of Canada | 338k | $18M | 96% | Sep 2025 |
|
| Legal & General Group | 335k | $26M | -1% | Dec 2025 |
|
| Partner Fund Management | 327k | $17M | -37% | Sep 2025 |
|
| Affinity Asset Advisors | 320k | $25M | 392% | Dec 2025 |
|
| Emerald Mutual Fund Advisers, Trust | 317k | $24M | -23% | Dec 2025 |
|
| Woodline Partners | 301k | $23M | 52% | Dec 2025 |
|
| Jpmorgan Chase & Co | 294k | $15M | 100% | Sep 2025 |
|
| Nicholas Investments Partners | 285k | $22M | 5% | Dec 2025 |
|
| Swiss National Bank | 283k | $22M | 2% | Dec 2025 |
|
| First Trust Advisors | 282k | $22M | 15% | Dec 2025 |
|
| Squarepoint Ops | 280k | $21M | 613% | Dec 2025 |
|
| Artisan Partners Limited Partnership | 279k | $21M | -16% | Dec 2025 |
|
| Candriam Luxembourg S.C.A. | 279k | $21M | 87% | Dec 2025 |
|
| Victory Capital Management | 277k | $21M | -42% | Dec 2025 |
|
| Eagle Health Investments | 259k | $20M | 0% | Dec 2025 |
|
| Advisor Group Holdings | 252k | $19M | -3% | Dec 2025 |
|
| Skandinaviska Enskilda Banken AB | 238k | $18M | 60% | Dec 2025 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 234k | $18M | 5% | Dec 2025 |
|
| Royce & Associates | 233k | $18M | 0% | Dec 2025 |
|
| Fisher Investments | 232k | $18M | 100% | Dec 2025 |
|
| Wells Fargo & Company | 232k | $18M | 56% | Dec 2025 |
|
| Sei Investments | 225k | $17M | 93% | Dec 2025 |
|
| Neuberger Berman Group | 221k | $17M | 1% | Dec 2025 |
|
| Millennium Management | 220k | $11M | -66% | Sep 2025 |
|
| Rhumbline Advisers | 214k | $16M | -12% | Dec 2025 |
|
| ADAR1 Capital Management | 213k | $16M | -22% | Dec 2025 |
|
| CalPERS | 208k | $16M | -18% | Dec 2025 |
|
| Axiom International Investors | 208k | $16M | 89% | Dec 2025 |
|
| Philosophy Capital Management | 200k | $15M | -48% | Dec 2025 |
|
| Leucadia National Corporation | 200k | $15M | 100% | Dec 2025 |
|
| Fred Alger Management | 197k | $10M | 729% | Sep 2025 |
|
| Portman Square Capital | 186k | $14M | -43% | Dec 2025 |
|
| Boone Capital Management | 185k | $14M | -60% | Dec 2025 |
|
| WCM Investment Management | 175k | $13M | -33% | Dec 2025 |
|
| Hillsdale Investment Management | 165k | $13M | 0% | Dec 2025 |
|
| Mizuho Markets Americas | 162k | $12M | 15% | Dec 2025 |
|
| Granahan Investment Management | 161k | $8.4M | 95% | Sep 2025 |
|
| TD Asset Management | 144k | $11M | 62% | Dec 2025 |
|
| LMR Partners | 144k | $11M | -3% | Dec 2025 |
|
| HealthInvest Partners AB | 141k | $11M | -19% | Dec 2025 |
|
| Prudential Financial | 137k | $11M | -18% | Dec 2025 |
|
| California State Teachers Retirement System | 134k | $10M | 0% | Dec 2025 |
|
| Moody Aldrich Partners | 131k | $10M | 83% | Dec 2025 |
|
| ExodusPoint Capital Management | 125k | $9.6M | 312% | Dec 2025 |
|
| Freestone Grove Partners | 125k | $9.6M | 34% | Dec 2025 |
|
| Wolverine Trading | 120k | $6.2M | 20% | Sep 2025 |
|
| Raymond James Financial | 118k | $9.0M | 10% | Dec 2025 |
|
| Algert Coldiron Investors | 115k | $6.0M | 77% | Sep 2025 |
|
| Qube Research & Technologies | 114k | $8.7M | -70% | Dec 2025 |
|
| CastleArk Management | 114k | $8.7M | -8% | Dec 2025 |
|
| Creative Planning | 111k | $8.5M | 18% | Dec 2025 |
|
| Erste Asset Management GmbH | 110k | $8.3M | -21% | Dec 2025 |
|
| Nan Fung Trinity | 110k | $8.4M | 100% | Dec 2025 |
|
| Arrowpoint Asset Management | 110k | $5.7M | 0% | Sep 2025 |
|
| Sphera Funds Management | 108k | $8.2M | -37% | Dec 2025 |
|
| Mirae Asset Securities | 104k | $7.9M | 100% | Dec 2025 |
|
| Rock Springs Capital Management | 104k | $7.9M | 22% | Dec 2025 |
|
| Graham Capital Management | 101k | $7.7M | -64% | Dec 2025 |
|
| DekaBank Deutsche Girozentrale | 100k | $3.4M | 0% | Dec 2025 |
|
| Monashee Investment Management | 100k | $7.6M | -50% | Dec 2025 |
|
| EFG Asset Management | 100k | $5.2M | 38% | Sep 2025 |
|
| AQR Capital Management | 99k | $5.1M | -37% | Sep 2025 |
|
| Eudaimonia Asset Management | 95k | $7.3M | -2% | Dec 2025 |
|
| New York State Common Retirement Fund | 94k | $7.2M | -8% | Dec 2025 |
|
| HighTower Advisors | 92k | $7.0M | -60% | Dec 2025 |
|
| State of Wisconsin Investment Board | 91k | $7.0M | 0% | Dec 2025 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 91k | $6.9M | -28% | Dec 2025 |
|
| Point72 Europe | 90k | $4.6M | 100% | Sep 2025 |
|
| EFG International | 88k | $6.7M | 100% | Dec 2025 |
|
| MetLife Investment Advisors | 88k | $6.7M | -4% | Dec 2025 |
|
| Knott David M Jr | 85k | $6.5M | 0% | Dec 2025 |
|
| NEOS Investment Management | 84k | $6.5M | -13% | Dec 2025 |
|
| Tema Etfs | 83k | $6.4M | -14% | Dec 2025 |
|
| HighVista Strategies | 82k | $4.3M | 21% | Sep 2025 |
|
| Rhenman & Partners Asset Management AB | 82k | $6.2M | 100% | Dec 2025 |
|
| Exome Asset Management | 81k | $6.2M | -39% | Dec 2025 |
|
| Rafferty Asset Management | 80k | $6.1M | -47% | Dec 2025 |
|
| SG Americas Securities | 80k | $6.1M | 312% | Dec 2025 |
|
| Mirae Asset Global Etfs Holdings | 78k | $5.9M | -3% | Dec 2025 |
|
| Marshall Wace | 75k | $5.7M | -26% | Dec 2025 |
|
| Cetera Investment Advisers | 73k | $5.6M | -3% | Dec 2025 |
|
| Cinctive Capital Management | 70k | $5.4M | -27% | Dec 2025 |
|
| Edgestream Partners | 55k | $4.2M | -46% | Dec 2025 |
|
| Brevan Howard Capital Management | 52k | $2.7M | -50% | Sep 2025 |
|
| Assenagon Asset Management | 34k | $2.6M | -87% | Dec 2025 |
|
| Prosight Management | 30k | $2.3M | -89% | Dec 2025 |
|
| Tudor Investment Corporation | 12k | $597k | -93% | Sep 2025 |
|
| 683 Capital Management | 2.0k | $153k | -99% | Dec 2025 |
|
Who sold out of Bridgebio Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Macquarie Group | Sep 2025 | 1.9M | $100M |
| T. Rowe Price Investment Management | Sep 2025 | 1.1M | $55M |
| Catalio Capital Management | Sep 2025 | 623k | $32M |
| Renaissance Technologies | Sep 2025 | 322k | $17M |
| Burkehill Global Management | Sep 2025 | 275k | $14M |
| Zimmer Partners | Sep 2025 | 184k | $9.6M |
| Stempoint Capital | Sep 2025 | 127k | $6.6M |
| Readystate Asset Management | Sep 2025 | 117k | $6.1M |
| Alyeska Investment Group | Sep 2025 | 103k | $5.3M |
| Superstring Capital Management | Sep 2025 | 89k | $4.6M |
| Susquehanna Fundamental Investments | Sep 2025 | 86k | $4.5M |